The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Buscopan 10 mg Coated Tablets

10 milligram(s) Coated tablet

Sanofi-Aventis Ireland Limited T/A SANOFIPA0540/181/002

Main Information

Trade NameBuscopan 10 mg Coated Tablets
Active SubstancesHyoscine butylbromide
Strength10 milligram(s)
Dosage FormCoated tablet
Licence HolderSanofi-Aventis Ireland Limited T/A SANOFI
Licence NumberPA0540/181/002

Group Information

ATC CodeA03BB Belladonna alkaloids, semisynthetic, quaternary ammonium compounds
A03BB01 butylscopolamine

Status

Authorised/WithdrawnAuthorised
Licence Issued01/04/1979
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to the general public
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version
« Back